# The Efficacy of a Combination Regimen in Patients With Mild to Moderate Probable Alzheimer's Disease

> **NCT01921972** · PHASE4 · COMPLETED · sponsor: **Charite University, Berlin, Germany** · enrollment: 232 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** Galantamine CR
- **DRUG:** Memantine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01921972
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2008-11
- **Final completion:** 2009-05
- **Target enrollment:** 232 (ACTUAL)
- **Last updated:** 2013-08-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01921972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01921972, "The Efficacy of a Combination Regimen in Patients With Mild to Moderate Probable Alzheimer's Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01921972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*